Outcomes of de novo extended-release tacrolimus use (Advagraf®) in kidney transplantation: 1-year, single-center experience

MLA

Gülçin TÜRKMEN SARIYILDIZ, et al. Outcomes of de Novo Extended-Release Tacrolimus Use (Advagraf®) in Kidney Transplantation: 1-Year, Single-Center Experience. July 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aafddac34a06b0030ad5805ab204ca99&authtype=sso&custid=ns315887.

APA

Gülçin TÜRKMEN SARIYILDIZ, Mehmet Emin DEMİR, Zafer ERCAN, Ulaş SÖZENER, Canan ÇİÇEK, Aykut İlker ARSLAN, & Fatma Necla ÖZŞEKER. (2022). Outcomes of de novo extended-release tacrolimus use (Advagraf®) in kidney transplantation: 1-year, single-center experience.

Chicago

Gülçin TÜRKMEN SARIYILDIZ, Mehmet Emin DEMİR, Zafer ERCAN, Ulaş SÖZENER, Canan ÇİÇEK, Aykut İlker ARSLAN, and Fatma Necla ÖZŞEKER. 2022. “Outcomes of de Novo Extended-Release Tacrolimus Use (Advagraf®) in Kidney Transplantation: 1-Year, Single-Center Experience,” July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aafddac34a06b0030ad5805ab204ca99&authtype=sso&custid=ns315887.